Scientists use AI to map Brain's response to new depression drug
NCT ID NCT06570369
Summary
This early-stage study aims to understand if an investigational drug called SP-624 changes brain activity patterns in healthy adults and people with major depression. Researchers will use a special cap to measure brain waves and AI software to analyze them. The study will also check if the drug improves memory and is safe for people to take for two weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alivation Research
COMPLETEDLincoln, Nebraska, 68526, United States
-
CenExel CNS
RECRUITINGGarden Grove, California, 92845, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.